
A report describing the application of the Speedometer framework to analyze select interventions that address maternal, newborn, and child health. In addition to analyzing and reporting on launch and scale trends and patterns for these interventions, this report provides recommendations for the community of funders and policymakers to enable proven interventions to reach more people rapidly.

New and enduring global health challenges need effective, proven solutions and interventions that can be scaled to reach the most vulnerable populations.

This case study is part of a series that explores pathways and important factors that contribute to the development and uptake of global health interventions - from proof of concept to scale-up.

This case study is part of a series that explores pathways and important factors that contribute to the development and uptake of global health interventions - from proof of concept to scale-up.

A call to action for world leaders to convene a "Global Pandemic Response and Vaccination Summit" to create a coordinated, global response to the pandemic.

The COVID-19 vaccine manufacturing landscape is highly dynamic, both expanding and contracting almost daily. This issue brief is the first analysis of publicly available information about COVID vaccine manufacturing. Updated data available.

In this paper we analyze the impact of COVID-19 on maternal and child health services in Ethiopia and India at the outset of the pandemic from April to September 2020.

Tuberculosis (TB) is one of the leading causes of morbidity and mortality worldwide. Each year around 10 million people gets infected by TB and more than a million die from it. Drug-resistant TB is an increasing global health threat.

Sayana® Press (SP) is an easy-to-administer three-month injectable contraceptive (depot-medroxyprogesterone acetate, DMPA-SC) that has been hailed as a game changer in family planning.

Explore the pathways and important factors that contribute to the development and uptake of global health interventions - from proof of concept to scale-up.